Virtu Financial LLC Aveo Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 17, 2022
SELL
$4.69 - $7.4 $48,503 - $76,530
-10,342 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$5.12 - $6.89 $52,951 - $71,256
10,342 New
10,342 $64,000
Q2 2021

Sep 17, 2021
SELL
$6.21 - $7.45 $205,433 - $246,453
-33,081 Closed
0 $0
Q1 2021

May 19, 2021
BUY
$5.97 - $15.28 $197,493 - $505,477
33,081 New
33,081 $242,000
Q4 2020

Feb 24, 2021
SELL
$5.08 - $6.68 $124,851 - $164,174
-24,577 Closed
0 $0
Q3 2020

Dec 11, 2020
BUY
$4.16 - $6.26 $102,240 - $153,852
24,577 New
24,577 $146,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email